Speaker(s): 

Nico Gioupis PharmD. Candidate, Geisinger - has nothing to disclose.

Karamvir Singh PharmD. Candidate, Geisinger - has nothing to disclose.

Moderator(s): 

Christopher DeFrancesco, PharmD, Clinical Pharmacist / Asst Pharmacy Residency Program Director Geisinger - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

1. Compare sepsis definitions and diagnostic criteria.
2. Explain key changes in sepsis management, including screening, fluid resuscitation, antimicrobial therapy, and vasopressor use.
3. Apply updated sepsis guidelines to clinical scenarios to improve patient outcomes and reduce sepsis-related morbidity and mortality.

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Christopher DeFrancesco PharmD, RPH; Anil Singh MD; Roop Parlapalli, MD, FHM, FACP; Carolyn Chilewshi, PA-C; Emilie Detweiler, PharmD, RPh; Alexa Kerecman, CRNP; John Sacino, CPhT, and Miranda Steigler, PharmD, RPh have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None.